日本の抗真菌薬市場レポート 薬剤クラス別(アゾール系、エキノカンディン系、ポリエン系、アリルアミン類、その他)、適応症別(皮膚糸状菌症、アスペルギルス症、カンジダ症、その他)、地域別 2025-2033

日本の抗真菌薬市場レポート 薬剤クラス別(アゾール系、エキノカンディン系、ポリエン系、アリルアミン類、その他)、適応症別(皮膚糸状菌症、アスペルギルス症、カンジダ症、その他)、地域別 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A27942

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Japan Antifungal Drugs Market - Introduction

    4.1    Overview
    4.2    Market Dynamics
    4.3    Industry Trends
    4.4    Competitive Intelligence
5   Japan Antifungal Drugs Market Landscape
    5.1    Historical and Current Market Trends (2019-2024)
    5.2    Market Forecast (2025-2033)
6   Japan Antifungal Drugs Market - Breakup by Drug Class
    6.1    Azoles
        6.1.1 Overview
        6.1.2 Historical and Current Market Trends (2019-2024)
        6.1.3 Market Segmentation
           6.1.3.1 Voriconazole (Vfend)
           6.1.3.2 Posaconazole (Noxafil)
           6.1.3.3 Clotrimazole (Canesten)
           6.1.3.4 Isavuconazole (Cresemba)
           6.1.3.5 Others
        6.1.4 Market Forecast (2025-2033)
    6.2    Echinocandins
        6.2.1 Overview
        6.2.2 Historical and Current Market Trends (2019-2024)
        6.2.3 Market Segmentation
           6.2.3.1 Caspofungin (Cancidas)
           6.2.3.2 Micafungin (Mycamine/ Funguard)
           6.2.3.3 Others
        6.2.4 Market Forecast (2025-2033)
    6.3    Polyenes
        6.3.1 Overview
        6.3.2 Historical and Current Market Trends (2019-2024)
        6.3.3 Market Segmentation
           6.3.3.1 Amphotericin (AmBisome)
           6.3.3.2 Others
        6.3.4 Market Forecast (2025-2033)
    6.4    Allylamines
        6.4.1 Overview
        6.4.2 Historical and Current Market Trends (2019-2024)
        6.4.3 Market Segmentation
           6.4.3.1 Terbinafine (Lamisil)
           6.4.3.2 Others
        6.4.4 Market Forecast (2025-2033)
    6.5    Others
        6.5.1 Historical and Current Market Trends (2019-2024)
        6.5.2 Market Forecast (2025-2033)
7   Japan Antifungal Drugs Market - Breakup by Indication
    7.1    Dermatophytosis
        7.1.1 Overview
        7.1.2 Historical and Current Market Trends (2019-2024)
        7.1.3 Market Forecast (2025-2033)
    7.2    Aspergillosis
        7.2.1 Overview
        7.2.2 Historical and Current Market Trends (2019-2024)
        7.2.3 Market Forecast (2025-2033)
    7.3    Candidiasis
        7.3.1 Overview
        7.3.2 Historical and Current Market Trends (2019-2024)
        7.3.3 Market Segmentation
           7.3.3.1 Invasive Candidiasis
           7.3.3.2 Calcium Carbonate
           7.3.3.3 Vulvovaginal Candidiasis (VVC)
           7.3.3.4 Mouth/Throat/Esophageal Candidiasis
           7.3.3.5 Others
        7.3.4 Market Forecast (2025-2033)
    7.4    Others
        7.4.1 Historical and Current Market Trends (2019-2024)
        7.4.2 Market Forecast (2025-2033)
8   Japan Antifungal Drugs Market – Breakup by Region
    8.1    Kanto Region
        8.1.1 Overview
        8.1.2 Historical and Current Market Trends (2019-2024)
        8.1.3 Market Breakup by Drug Class
        8.1.4 Market Breakup by Indication
        8.1.5 Key Players
        8.1.6 Market Forecast (2025-2033)
    8.2    Kansai/Kinki Region
        8.2.1 Overview
        8.2.2 Historical and Current Market Trends (2019-2024)
        8.2.3 Market Breakup by Drug Class
        8.2.4 Market Breakup by Indication
        8.2.5 Key Players
        8.2.6 Market Forecast (2025-2033)
    8.3    Central/ Chubu Region
        8.3.1 Overview
        8.3.2 Historical and Current Market Trends (2019-2024)
        8.3.3 Market Breakup by Drug Class
        8.3.4 Market Breakup by Indication
        8.3.5 Key Players
        8.3.6 Market Forecast (2025-2033)
    8.4    Kyushu-Okinawa Region
        8.4.1 Overview
        8.4.2 Historical and Current Market Trends (2019-2024)
        8.4.3 Market Breakup by Drug Class
        8.4.4 Market Breakup by Indication
        8.4.5 Key Players
        8.4.6 Market Forecast (2025-2033)
    8.5    Tohoku Region
        8.5.1 Overview
        8.5.2 Historical and Current Market Trends (2019-2024)
        8.5.3 Market Breakup by Drug Class
        8.5.4 Market Breakup by Indication
        8.5.5 Key Players
        8.5.6 Market Forecast (2025-2033)
    8.6    Chugoku Region
        8.6.1 Overview
        8.6.2 Historical and Current Market Trends (2019-2024)
        8.6.3 Market Breakup by Drug Class
        8.6.4 Market Breakup by Indication
        8.6.5 Key Players
        8.6.6 Market Forecast (2025-2033)
    8.7    Hokkaido Region
        8.7.1 Overview
        8.7.2 Historical and Current Market Trends (2019-2024)
        8.7.3 Market Breakup by Drug Class
        8.7.4 Market Breakup by Indication
        8.7.5 Key Players
        8.7.6 Market Forecast (2025-2033)
    8.8    Shikoku Region
        8.8.1 Overview
        8.8.2 Historical and Current Market Trends (2019-2024)
        8.8.3 Market Breakup by Drug Class
        8.8.4 Market Breakup by Indication
        8.8.5 Key Players
        8.8.6 Market Forecast (2025-2033)
9   Japan Antifungal Drugs Market – Competitive Landscape
    9.1    Overview
    9.2    Market Structure
    9.3    Market Player Positioning
    9.4    Top Winning Strategies
    9.5    Competitive Dashboard
    9.6    Company Evaluation Quadrant
10  Profiles of Key Players
    10.1    Company A 
        10.1.1 Business Overview
        10.1.2 Product Portfolio
        10.1.3 Business Strategies
        10.1.4 SWOT Analysis
        10.1.5 Major News and Events
    10.2    Company B
        10.2.1 Business Overview
        10.2.2 Product Portfolio
        10.2.3 Business Strategies
        10.2.4 SWOT Analysis
        10.2.5 Major News and Events
    10.3    Company C
        10.3.1 Business Overview
        10.3.2 Product Portfolio
        10.3.3 Business Strategies
        10.3.4 SWOT Analysis
        10.3.5 Major News and Events
    10.4    Company D 
        10.4.1 Business Overview
        10.4.2 Product Portfolio
        10.4.3 Business Strategies
        10.4.4 SWOT Analysis
        10.4.5 Major News and Events
    10.5    Company E
        10.5.1 Business Overview
        10.5.2 Product Portfolio
        10.5.3 Business Strategies
        10.5.4 SWOT Analysis
        10.5.5 Major News and Events    
    
Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

11  Japan Antifungal Drugs Market - Industry Analysis
    11.1    Drivers, Restraints, and Opportunities
        11.1.1 Overview
        11.1.2 Drivers
        11.1.3 Restraints
        11.1.4 Opportunities
    11.2   Porters Five Forces Analysis
        11.2.1 Overview
        11.2.2 Bargaining Power of Buyers
        11.2.3 Bargaining Power of Suppliers
        11.2.4 Degree of Competition
        11.2.5 Threat of New Entrants
        11.2.6 Threat of Substitutes
    11.3    Value Chain Analysis
12  Appendix

日本の抗真菌薬市場レポート 薬剤クラス別(アゾール系、エキノカンディン系、ポリエン系、アリルアミン類、その他)、適応症別(皮膚糸状菌症、アスペルギルス症、カンジダ症、その他)、地域別 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials